Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 09, 2016 7:46 AM ET

Healthcare Equipment and Supplies

Company Overview of X-spine Systems, Inc.

Company Overview

X-spine Systems, Inc. is a spinal implant company that develops spinal implants and instrumentation for the treatment of spinal disease worldwide. The company offers cervical products, such as cervical plating systems, cervical allograft interbody spacers, cervical interbody spacer systems, cervical plasma coated PEEK, cervical integrated fusion systems, and cervical plates and screws; cervico-thoracic solutions, including spinal fixation systems; thoracolumbar solutions, such as interspinous fusion systems, anterior lumbar buttress plating solutions, plasma coated PEEK implants, PEEK lumbar systems, spinal facet screw systems, pedicle screw systems, lumbar integrated fusion systems, pedicle...

452 Alexandersville Road

Miamisburg, OH 45342

United States

Founded in 2003

Phone:

937-847-8400

Fax:

937-847-8410

Key Executives for X-spine Systems, Inc.

Chief Executive Officer, President and Xtant Medical Chief Scientific Officer
Age: 45
Chief Financial Officer
General Counsel and Compliance Officer
Vice President of Marketing & Business Development
Vice President of Engineering
Compensation as of Fiscal Year 2015.

X-spine Systems, Inc. Key Developments

Xtant™ Medical Receives Clearance of Expanded Indication for Ilium Fixation and Deformity

Xtant Medical Holdings, Inc. announced that its wholly owned subsidiary, X-spine Systems, Inc. received FDA clearance of expanded indications to include ilium fixation as well as extended length screws for the Fortex® and the Xpress™ 2 Pedicle Screw System. The extended length screws are compatible with X-spine's current Fortex and Xpress instrument systems, offering a comprehensive pedicle screw portfolio. These dual lead, non-cannulated screws are indicated for use in posterior, non-cervical, T1-S2/Ilium pedicle spinal fixation. They are intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of degenerative spondylolisthesis, fracture, dislocation, scoliosis, kyphosis, spinal tumors, and failed previous fusion.

X-Spine Systems, Inc. Receives FDA clearance of the Aranax Cervical Plate

Xtant Medical Holdings, Inc. announced that its wholly owned subsidiary, X-spine Systems, received FDA clearance of the Aranax Cervical Plate. The Aranax System represents the latest generation of anterior cervical fixation with an enhanced locking mechanism, low profile features, increased screw angulation and intuitive instrumentation. Indications for the Aranax implant include fusion on one to four contiguous levels of the cervical spine, through an anterior approach (C1-C7 inclusive). The sterile packaging will reduce facility processing costs for hospitals and improve procedure planning.

X-Spine Systems, Inc. Reports Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2015

X-spine Systems, Inc. reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2015. For the quarter, revenue was $11,729,509 against $12,793,067 for the same period of last year. Income from operations was $1,124,496 against $2,410,541 for the same period of last year. Income before city income tax expense was $1,037,711 against $2,260,541 for the same period of last year. Net income was $1,051,500 against $2,215,331 for the same period of last year. For the six months, revenue was $23,954,756 against $20,706,023 for the same period of last year. Income from operations was $1,967,625 against $2,937,383 for the same period of last year. Income before city income tax expense was $1,801,166 against $2,637,383 for the same period of last year. Net income was $1,790,023 against $2,559,913 for the same period of last year. Net cash provided by operating activities was $1,735,805 against $2,626,223 for the same period of last year. Patent and trademark purchases was $81,716 against $104,189 for the same period of last year. Purchase property and equipment was $1,191,712 against $2,233,598 for the same period of last year.

Similar Private Companies By Industry

Company Name Region
Radiometer America, Inc. United States
Thuasne North America, Inc. United States
Bay Point Group LLC United States
Avisa Pharma Inc. United States
Bracco Diagnostics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
July 27, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact X-spine Systems, Inc., please visit www.x-spine.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.